A pharmaceutical composition comprising a poorly water-soluble drug, a pharmaceutically acceptable commonly used pharmaceutical excipient or adjuvant, and a carrier material, wherein the carrier material is selected from the group consisting of compounds or conjugates as defined by Formula I, II, III, IV, V, VI, VII, VIII, it may also comprise a pharmaceutically acceptable salt thereof or a solvate thereof;
- wherein the poorly water-soluble drug is selected from the group consisting of paclitaxel, docetaxel, cabazitaxel, Vinblastine, vincristine, lipitor, artemisinin, dihydroartemisinin, indomethacin, capecitabine, oxaliplatin, gefitinib, doxorubicin, irinotecan, gemcitabine, pemetrexed, temozolomide, imatinib, vinorelbine, letrozole, teniposide, etoposide, podophyllotoxin, camptothecin, 10-hydroxycamptothecin, 9-hydroxyl-Camptothecin, 7-ethyl-10-hydroxycamptothecin, SN-38, topotecan, irinotecan, vindesine, vinflunine, vinpocetine, desmethylcantharidin, silybin, propofol, florfenicol, mitiglinide, sirolimus, buprofen, nitrendipine, nicardipine, nimodipine, grid Zitt, cisapride, nifedipine, felodipine, glibenclamide, acyclovir, oleanolic acid, breviscapine, ferulic acid, paracetamol, palmitoyl Benikedine, vitamin A, vitamin D, tamoxifen, noviben, valproic acid, tacrolimus, cyclosporine A, amphotericin B, ketoconazole, domperidone, sulpiride, fenofibine, bezafibrate, azithromycin, itraconazole, miconazole, propofol, brimonidine, latanoprost, silybin, curcumin, Adriamycin, erythromycin, roxithromycin, Fuximin, cisapride, cyclosporin, diclofenac, felodipine, ibuprofen, nicardipine, nifedipine, terfenadine, theophylline, ketoprofen, furosemide, spironolactone, dipyrimidine Damo, piroxicam, mefenamic acid, trichlorothiazide, guanolol, saturated or unsaturated fatty acids (such as stearic acid, palmitic acid, oleic acid, linoleic acid, DHA, etc.) or combinations thereof.